TDOC Teladoc Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TDOC

Price (delayed)

$225.25

Market cap

$32.65B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.44

Enterprise value

$32.45B

Sector: Healthcare
Industry: Health Information Services
Website: https://teladochealth.com/

Highlights

Teladoc Health's equity has surged by 125% YoY and by 72% QoQ
TDOC's revenue has soared by 67% year-on-year and by 21% since the previous quarter
The company's EPS fell by 12% QoQ but it rose by 2% YoY
TDOC's debt has soared by 114% YoY
TDOC's quick ratio is down by 44% since the previous quarter

Key stats

What are the main financial stats of TDOC
Market
Shares outstanding
144.96M
Market cap
$32.65B
Enterprise value
$32.45B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
8.2
Price to sales (P/S)
21.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
37.42
Earnings
Revenue
$867.13M
EBIT
-$72.48M
EBITDA
-$23.36M
Free cash flow
$61.5M
Per share
EPS
-$1.44
Free cash flow per share
$0.74
Book value per share
$27.47
Revenue per share
$10.37
TBVPS
$16.4
Balance sheet
Total assets
$3.45B
Total liabilities
$1.22B
Debt
$983.81M
Equity
$2.23B
Working capital
$1.11B
Liquidity
Debt to equity
0.44
Current ratio
6.52
Quick ratio
6.35
Net debt/EBITDA
8.71
Margins
EBITDA margin
-2.7%
Gross margin
62.7%
Net margin
-12.7%
Operating margin
-7.3%
Efficiency
Return on assets
-4.9%
Return on equity
-8%
Return on invested capital
-9.7%
Return on capital employed
-2.2%
Return on sales
-8.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TDOC stock price

How has the Teladoc Health stock price performed over time
Intraday
-0.13%
1 week
-1.11%
1 month
14.86%
1 year
139.63%
YTD
12.65%
QTD
12.65%

Financial performance

How have Teladoc Health's revenue and profit performed over time
Revenue
$867.13M
Gross profit
$543.89M
Operating income
-$63.5M
Net income
-$110.21M
Gross margin
62.7%
Net margin
-12.7%
TDOC's revenue has soared by 67% year-on-year and by 21% since the previous quarter
Teladoc Health's gross profit has soared by 55% YoY and by 20% from the previous quarter
The operating margin has soared by 54% YoY and by 18% from the previous quarter
TDOC's net margin is up by 37% YoY and by 3.8% from the previous quarter

Growth

What is Teladoc Health's growth rate over time

Valuation

What is Teladoc Health stock price valuation
P/E
N/A
P/B
8.2
P/S
21.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
37.42
The company's EPS fell by 12% QoQ but it rose by 2% YoY
Teladoc Health's equity has surged by 125% YoY and by 72% QoQ
The stock's price to book (P/B) is 58% more than its 5-year quarterly average of 5.2 but 10% less than its last 4 quarters average of 9.1
The P/S is 101% above the 5-year quarterly average of 10.8 and 22% above the last 4 quarters average of 17.8
TDOC's revenue has soared by 67% year-on-year and by 21% since the previous quarter

Efficiency

How efficient is Teladoc Health business performance
The company's return on sales rose by 47% YoY and by 16% QoQ
Teladoc Health's return on invested capital has increased by 41% YoY and by 14% QoQ
TDOC's return on assets is up by 27% year-on-year and by 8% since the previous quarter
Teladoc Health's ROE has increased by 23% YoY and by 9% from the previous quarter

Dividends

What is TDOC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TDOC.

Financial health

How did Teladoc Health financials performed over time
Teladoc Health's total assets is 183% higher than its total liabilities
Teladoc Health's total assets has surged by 120% YoY and by 43% QoQ
The total liabilities has soared by 112% YoY and by 8% from the previous quarter
TDOC's debt is 56% less than its equity
Teladoc Health's equity has surged by 125% YoY and by 72% QoQ
The debt to equity has contracted by 41% from the previous quarter and by 4.3% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.